Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China. [electronic resource]
Producer: 20180904Description: 423-431 p. digitalISSN:- 1432-1041
- Acute Coronary Syndrome -- diagnostic imaging
- Adenosine -- analogs & derivatives
- Aged
- Asian People -- genetics
- Chi-Square Distribution
- China
- Clinical Decision-Making
- Clopidogrel
- Cytochrome P-450 CYP2C19 -- genetics
- Drug-Eluting Stents
- Female
- Gene Frequency
- Genetic Predisposition to Disease
- Hemorrhage -- chemically induced
- Heterozygote
- Homozygote
- Humans
- Hypertension -- complications
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Myocardial Infarction -- blood
- Percutaneous Coronary Intervention -- adverse effects
- Pharmacogenetics
- Pharmacogenomic Variants
- Phenotype
- Platelet Aggregation Inhibitors -- adverse effects
- Polymorphism, Genetic
- Precision Medicine
- Retrospective Studies
- Risk Factors
- Stroke -- blood
- Ticagrelor
- Ticlopidine -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.